12 results on '"Adorno, G."'
Search Results
2. Using the Eco-Map and Ecosystems Perspective to Guide Skilled Nursing Facility Discharge Planning.
- Author
-
Miller, V. J., Fields, N. L., Adorno, G., and Smith-Osborne, A.
- Subjects
- *
DISCHARGE planning , *ELDER care , *BIOTIC communities , *MEDICAL care , *PATIENT-professional relations , *NURSING care facilities , *SOCIAL case work , *PATIENT-centered care , *PSYCHOLOGY - Abstract
Growing numbers of seniors across the United States require skilled nursing facility care after an inpatient hospital stay. Previous studies indicate that roughly 20 percent of all hospitalized Medicare beneficiaries are admitted to a skilled nursing facility following a qualifying hospital stay. Social workers address psychosocial problems, social support, networks, and healthcare needs during transitions in care, particularly discharge planning. Ecosystems perspective and the eco-map as a discharge planning tool is presented. Social workers can use these tools to examine the patient with respect to their transactional relationships with systems. This will further will facilitate provision of wrap-around services upon discharge. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
3. Peripheral Blood Progenitor Cell Collection Using the New AMICUS Separator.
- Author
-
Adorno, G., Lamanda, M., Del Proposto, G., Ballatore, G., Bruno, A., Del Poeta, G., Postorino, M., Del Principe, M.I., Maurillo, L., Masi, M., Isacchi, G., and Amadori, S.
- Subjects
- *
BLOOD cells , *BLOOD collection , *GRANULOCYTE-colony stimulating factor - Abstract
BACKGROUND PBPC transplantation has become a widely accepted therapeutic option for patients with chemotherapy-sensitive malignancies. PBPCs facilitate even the transplantation of mismatched allogeneic cells, because of their better engraftment. PBPCs are harvested by leukapheresis after mobilization with G-CSF or chemotherapy and G-CSF. To improve the purity and yield of PBPC grafts, to ensure reproducibility of the procedure and to reduce platelet loss in the patient/donor, different fully automated PBPC collection systems were developed. We report here our experience with the new Amicus blood cell separator. METHODS From July 2000 to March 2001, 46 procedures were performed. Six donors underwent leukaphereses after G-CSF administration (10-12 microgr/Kg/day) beginning on day 4; 14 patients were harvested after chemotherapy and G-CSF or GM-CSF mobilization, when the peripheral CD34+ cell count was >20 cells/micrL. Peripheral venous access was preferred whenever possible, otherwise femoral or subclavian catheters were used. Complete cell counts and CD34+ cell evaluations were done both in patients and donors, before and after each procedure and in all the products of the apheresis. RESULTS A median of 8.959 L of blood (range 3.585-17.021 ) was processed with a duration of 315 minutes (range 215-400) at a blood flow rate of 40 ml/min (range 25-70). ACD was used at a ratio of 1:14. The products of apheresis had a median volume of 143 ml (range 70-306) and a Hct of 12.9% (range 1.6-21). Platelet contamination was low (722 × 10[sup 9]/L, range 55-1,620), according to a low collection efficiency (12%, range 2-34) and a low decrease of platelet level both in donors and patients (21 × 10[sup 9]/L, range 3-83); in contrast, CD34 + cell collection efficiency was high (59.5%, range 15-97). No adverse affects were observed. CONCLUSIONS Amicus blood cell separator has a high collection efficiency for PBPC collections and improves donor safety by reducing platelet loss. [ABSTRACT FROM AUTHOR]
- Published
- 2001
4. COVID-19 infection: a review of hematological and morphological features.
- Author
-
Amoroso, A.D., Bongo, S., Bernardini, S., Adorno, G., Massoud, R., and Morello, M.
- Subjects
- *
COVID-19 - Published
- 2024
- Full Text
- View/download PDF
5. THERAPEUTIC EFFICIENCY OF PLATELET GEL FOR THE TREATMENT OF ORAL ULCERS RELATED TO CHRONIC GRAFT VERSUS HOST DISEASE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION.
- Author
-
PICARDI, A., FERRARO, A. S., MIRANDA, M., MECONI, F., LANTI, A., ADORNO, G., ARCESE, W., and BOLLERO, P.
- Subjects
- *
GRAFT versus host disease , *BLOOD platelets , *STEM cell transplantation , *THERAPEUTICS - Abstract
Background. Platelet (PLT) gel has been successfully used in tissue regeneration of diabetic and surgical wounds through the releasing of growth factors such as basic fibroblast and PLT-derived growth factors. Based on this background, our previous clinical trial have assessed the feasibility and efficacy of PLT gel for the treatment of muco-cutaneous lesions related to graft versus host disease (GvHD) after allogeneic haematopoietic stem cell transplantion (HSCT). The promising results reported in a small series of 6 patients, of whom 1 with oral ulcers, represent the rationale of the present study. Materials and methods. The aim of this study was to verify the efficacy and safety of PLT gel for treating oral ulcers due to chronic GvHD. Allogeneic hemocomponents were used to obtain PLT gel with an automated system for the on-site preparation and application of patient (autologous) or healthy blood donor (allogeneic)-derived fibrin sealant or PLT-rich fibrin (Vivostat system, Vivostat A/S). Ten patients with multiple oral lesions related to chronic GvHD underwent allogeneic PLT gel as local therapy alone or in combination with systemic therapy in half of the cases. Results. After the second PLT gel application, all patients resumed the feeding and a significant improvement of the oral pain was observed. After a median of five PLT gel applications (range, 2-15), 7 out of 10 patients showed a complete response. No side effects were documented. Conclusion. These data confirm that the PLT gel may be used as a safe and effective tool, alone or in combination with systemic therapy, for the treatment of mucosal lesions of mouth related to cGvHD. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases.
- Author
-
Pica, F., Chimenti, M. S., Gaziano, R., Buè, C., Casalinuovo, I. A., Triggianese, P., Conigliaro, P., Di Carlo, D., Cordero, V., Adorno, G., Volpi, A., Perricone, R., and Garaci, E.
- Subjects
- *
THYMOSIN , *AUTOIMMUNE diseases , *IMMUNOLOGY of inflammation , *ANTIRHEUMATIC agents , *COHORT analysis , *LONGITUDINAL method , *SERUM - Abstract
Thymosin alpha 1 (Tα1) is a powerful modulator of immunity and inflammation. Despite years of studies, there are a few reports evaluating serum Tα1 in health and disease. We studied a cohort of healthy individuals in comparison with patients affected by chronic inflammatory autoimmune diseases. Sera from 120 blood donors (healthy controls, HC), 120 patients with psoriatic arthritis (PsA), 40 with rheumatoid arthritis (RA) and 40 with systemic lupus erythematosus (SLE), attending the Transfusion Medicine or the Rheumatology Clinic at the Policlinico Tor Vergata, Rome, Italy, were tested for Tα1 content by means of a commercial enzyme-linked immunosorbent assay (ELISA) kit. Data were analysed in relation to demographic and clinical characteristics of patients and controls. A gender difference was found in the HC group, where females had lower serum Tα1 levels than males ( P < 0·0001). Patients had lower serum Tα1 levels than HC ( P < 0·0001), the lowest were observed in PsA group ( P < 0·0001 versus all the other groups). Among all patients, those who at the time of blood collection were taking disease-modifying anti-rheumatic drugs (DMARD) plus steroids had significantly higher Tα1 levels than those taking DMARD alone ( P = 0·044) or no treatment ( P < 0·0001), but not of those taking steroids alone ( P = 0·280). However, whichever type of treatment was taken by the patients, serum Tα1 was still significantly lower than in HC and there was no treatment-related difference in PsA group. Further prospective studies are necessary to confirm and deepen these observations. They might improve our understanding on the regulatory role of Tα1 in health and disease and increase our knowledge of the pathogenesis of chronic inflammatory autoimmune diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Red blood cell depletion and cryopreservation of umbilical cord blood (UBC).
- Author
-
Bruno, A., Ballatore, G., Adorno, G., Caravita, T., Venditti, A., Del Poeta, G., Stasi, R., Buccisano, F., Santinelli, S., Picardi, A., Calugi, A., Tribalto, M., and Amadori, S.
- Subjects
- *
CRYOPRESERVATION of organs, tissues, etc. , *CORD blood , *FROZEN erythrocytes - Abstract
Focuses on a procedure for red blood cell (RBC) depletion and different cryoprotective solutions with or without rate-controlled freezing in an attempt to develop an inexpensive and simple method for processing and cryopreserving umbilical cord blood (UCB) hemopoietic cells. Cooling rate and concentration of the cryoprotectant; Analysis of RBC depletion by double gravity sedimentation and hyroxyethyl starch; Implications for UCB banks.
- Published
- 1997
- Full Text
- View/download PDF
8. Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia.
- Author
-
Gaziev, J, Isgrò, A, Marziali, M, Daniele, N, Gallucci, C, Sodani, P, Simone, M D, Adorno, G, Paciaroni, K, Andreani, M, Lanti, A, Del Proposto, G, Testi, M, De Angelis, G, Roveda, A, Alfieri, C, Saltarelli, F, and Lucarelli, G
- Subjects
- *
GRAFT versus host disease , *DISEASE incidence , *DISEASE risk factors , *JUVENILE diseases , *BONE marrow transplantation , *THALASSEMIA treatment - Abstract
We evaluated the incidence of GVHD, risk factors and the impact of graft composition on acute GVHD (aGVHD) in 92 children who underwent BMT for thalassemia following busulfan/cyclophosphamide (BUCY)-based conditioning regimens and GVHD prophylaxis with CSA/short-MTX and methylprednisolone. The incidence of grade 2-4 and 3-4 aGVHD was 35% (95% confidence interval (CI) 25-44) and 9% (95% CI 4-16), respectively. We found that CD3+ and CD34+ cell doses above the median were associated with high incidence of grade 2-4 aGVHD (49 vs 20%, P=0.005 and 46 vs 23%, P=0.021, respectively). In multivariate analysis, high CD3+ (hazard ratio (HR) 4.6; 95% CI 1.4-14.7; P=0.010) and CD34+ (HR 4.3; 95% CI 1.4-12.7; P=0.011) cell doses were associated with grade 2-4 aGVHD. We further examined the effect of CD3+ and CD34+ cell doses on aGVHD using quartile cutoff points and found a minimum threshold for CD3+ (38 × 106/kg) and CD34+ (4 × 106/kg) cells above which the incidence of grade 2-4 aGVHD is significantly increased. This study shows for the first time a positive correlation between the number of CD3+ and CD34+ cells and aGVHD in children receiving sibling BMT, and indicates that using tailored and more intensive post transplant immunosuppression may permit to better control aGVHD. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
9. KI and WU polyomaviruses and CD4+ cell counts in HIV-1-infected patients, Italy.
- Author
-
Babakir-Mina M, Ciccozzi M, Farchi F, Bergallo M, Cavallo R, Adorno G, Perno CF, Ciotti M, Babakir-Mina, Muhammed, Ciccozzi, Massimo, Farchi, Francesca, Bergallo, Massimiliano, Cavallo, Rossana, Adorno, Gaspare, Perno, Carlo Federico, and Ciotti, Marco
- Abstract
To investigate an association between KI and WU polyomavirus (KIPyV and WUPyV) infections and CD4+ cell counts, we tested HIV-1-positive patients and blood donors. No association was found between cell counts and virus infections in HIV-1-positive patients. Frequency of KIPyV infection was similar for both groups. WUPyV was more frequent in HIV-1-positive patients. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
10. Accurate prediction of autologous stem cell apheresis yields using a double variable-dependent method assures systematic efficiency control of continuous flow collection procedures.
- Author
-
Pierelli, L., Maresca, M., Piccirillo, N., Pupella, S., Gozzer, M., Foddai, M. L., Vacca, M., Adorno, G., Coppetelli, U., and Paladini, U.
- Subjects
- *
STEM cells , *HEMAPHERESIS , *BLOOD cell count , *BLOOD testing , *BLOOD cells - Abstract
Background and Objectives Stem cell collection is a standard procedure for the procurement of autologous grafts to rescue myelosuppression induced by high-dose treatments. Accurate prediction of collection yields may contribute to optimize planning and quality control of collection. Materials and Methods Data of 313 autologous haematopoietic stem cell (AHSC) evaluable collections performed in 208 patients with haematologic and non-haematologic neoplasms from seven centres were prospectively analysed to test the accuracy of yield predictions generated by a formula that required the input of peripheral blood (PB) CD34+ cell precount and desired PB volume to be processed. Data were matched in a standard linear regression, in a zero-point regression analysis and tested for prediction accuracy. Further 165 AHSC collections were analysed on a single-centre basis, using yield predictions as reference standards. Results Analysis showed high levels of correlation between measured collection yields (my) and predictions (py) ( R = 0·85; P = 0·000000) as well as high degree of prediction accuracy (my vs. py at paired t-test: P = 0·114781; median my/py ratio = 1·23). Analysis of additional 165 AHSC collections on a single-centre basis showed that the analysed centres had 70% or more measured yields comprising the 0·6–1·8 interval of the my/py ratio. The observance of the ‘efficiency’ my/py interval assured collection quality control in these centres confirming the reliability of the method. Conclusions This prediction method generates accurate and immediate yield predictions allowing collection planning and rapid efficiency control. As a consequence of our study, four centres out of seven use the described method to plan both leukapheresis number and single-procedure blood processing volume while the remaining three centres plan leukapheresis number on the basis of our predictions, maintaining a fixed single-procedure 200 ml/kg blood volume processing, according to their centre AHSC collection policy. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
11. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
- Author
-
Venditti, A., Battaglia, A., Del Poeta, G., Buccisano, F., Maurillo, L., Tamburini, A., Del Moro, B., Epiceno, A. M., Martiradonna, M., Caravita, T., Santinelli, S., Adorno, G., Picardi, A., Zinno, F., Lanti, A., Bruno, A., Suppo, G., Franchi, A., Franconi, G., and Amadori, S.
- Subjects
- *
CD4 antigen , *HEMATOPOIETIC agents - Abstract
Three different methods for determination of CD34+ cells in G-CSF-mobilized peripheral blood were compared. The methods were: the Milan/Mulhouse protocol, the ISHAGE guidelines for CD34+ cells enumeration and our own protocol. The procedure we have adopted is essentially a Milan/Mulhouse protocol-derived methodology combined with a multiparametric approach using the PAINT-A-GATE software analysis program. The samples were collected from 70 patients affected by acute leukemia, non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, myeloma and breast cancer who were scheduled to receive autologous PBSC transplantation. PBSC collection was performed following mobilization with subcutaneous G-CSF at 5–10 μg/kg/day. A minimum target of 2 × 106/kg CD34+ cells was considered an acceptable harvest to ensure a safe transplant. On average, three aphereses per patient were performed and a total of 204 apheresis samples were analyzed. Regression analysis of the percentage and absolute number of CD34+ cells, as calculated with each method, achieved an excellent correlation in spite of methodological differences. In fact, both CD34+dim and CD34+CD45- events were included in our gating strategy. In the setting of a triple staining associating CD34, CD38 and CD45, we identified a variable fraction of CD34+CD38+CD45- cells which would be otherwise undetected due to its CD45 negativity. To this end, we used a new technology referred to as laser-scanning cytometry (LSC) which allowed the isolation and morphological identification of CD34+CD45- cells. By comparing CD34+CD45+ and CD34+CD45- cells, we found that they share a common morphology, thus confirming the hypothesis that the latter are to be considered for CD34+ cell calculation. The median number of... [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
12. Corrigendum to “Treatment of diabetic ulcers, using autologous platelet and fibrinic gel. Experience with the FIBRINET® device” [Transf. Aphere. Sci. 43 (2010) 171–172]
- Author
-
Marinacci, M., Del Proposto, G., Catapano, A., Ferraro, A.S., Cerrone, P., Lanti, A., Uccioli, L., Giurato, L., D’Ambrogi, E., Adorno, G., and Isacchi, G.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.